The Deadpool
What happened to companies that raised private capital, from public records. Shutdowns and acquisitions are listed only with the evidence behind them.
Exits, not failures. Each acquisition is backed by a public record, such as an SEC change-in-control filing or the acquirer's filing announcing the completed deal.
477 companies
Lenz Therapeutics
BiotechnologyDel Mar, CA
Acquired by Graphite · Mar 2024
$136.2M raised (Form D) Last Form D Mar 2023
- Acquisition record· SEC EDGAR· Mar 22, 2024SEC EX-99.2 filed by LENZ Therapeutics, Inc.: Lenz Therapeutics became a wholly owned subsidiary of GraphiteSource
Nuvalent
Other Health CareCambridge, MA
Acquired · Jul 2026
$135.0M raised (Form D) Last Form D May 2021
- Acquisition record· SEC EDGAR· Jul 15, 2026SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Company website· Oct 18, 2026Website nuvalent.com: site shows the company name and its HQ locationSource
Apellis Pharmaceuticals
PharmaceuticalsCrestwood, KY
Acquired · May 2026
$134.9M raised (Form D) Last Form D Aug 2017
- Acquisition record· SEC EDGAR· May 14, 2026SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Actifio
Other TechnologyWaltham, MA
Acquired by Google Cloud. Read · Oct 2026
$134.0M raised (Form D) Last Form D Aug 2018
- Acquisition record· Company website· Oct 18, 2026Company website: "Actifio ... acquired by / now part of Google Cloud. Read"Source
- Company website· Wikidata· Oct 18, 2026Website actifio.com: listed by Wikidata (matched by SEC CIK)Source
Transphorm
Other TechnologyGoleta, CA
Acquired by Renesas · Mar 2024
$133.4M raised (Form D) Last Form D Jun 2015
- Acquisition record· SEC EDGAR· Mar 4, 2024SEC DEFM14A filed by Transphorm, Inc.: Transphorm became a wholly owned subsidiary of RenesasSource
Galera Therapeutics
PharmaceuticalsMalvern, PA
Acquired by Obsidian Therapeutics, Inc. · Aug 2026
$132.7M raised (Form D) Last Form D Jan 2025
- Acquisition record· SEC EDGAR· Aug 14, 2026SEC EX-99.3 filed by Obsidian Therapeutics, Inc.: Galera Therapeutics became a wholly owned subsidiary of Obsidian Therapeutics, Inc.Source
- Acquisition record· SEC EDGAR· Aug 4, 2026SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
ConvergeOne Holdings
OtherEagan, MN
Acquired · Jan 2019
$131.7M raised (Form D) Last Form D Mar 2018
- Acquisition record· SEC EDGAR· Jan 4, 2019SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
American Achievement Group Holding
OtherAustin, TX
Acquired by VISANT CORP · Mar 2014
$130.5M raised (Form D) Last Form D Oct 2015
- Acquisition record· SEC EDGAR· Mar 28, 2014SEC 10-K filed by VISANT CORP: VISANT CORP completed its acquisition of American Achievement Group HoldingSource
Rocket Fuel
Other TechnologyRedwood City, CA
Acquired · Sep 2017
$130.0M raised (Form D) Last Form D Sep 2014
- Acquisition record· SEC EDGAR· Sep 6, 2017SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website rocketfuel.com: listed by Wikidata (matched by SEC CIK)Source
Day One Biopharmaceuticals Holding
PharmaceuticalsSouth San Francisco, CA
Acquired · Apr 2026
$130.0M raised (Form D) Last Form D Feb 2021
- Acquisition record· SEC EDGAR· Apr 23, 2026SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Icosavax
BiotechnologySeattle, WA
Acquired · Feb 2024
$129.7M raised (Form D) Last Form D Apr 2021
- Acquisition record· SEC EDGAR· Feb 20, 2024SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Acquisition record· SEC EDGAR· Feb 20, 2024SEC EX-99.(A)(5)(H) filed by Icosavax, Inc.: the filer completed its acquisition of IcosavaxSource
Infinera
TelecommunicationsSunnyvale, CA
Acquired by Nokia · Feb 2025
$129.6M raised (Form D) Last Form D Oct 2018
- Acquisition record· SEC EDGAR· Feb 28, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Acquisition record· SEC EDGAR· Nov 5, 2024SEC EX-99.1 filed by Infinera Corp: INFINERA became a wholly owned subsidiary of NokiaSource
- Company website· Wikidata· Oct 18, 2026Website infinera.com: listed by Wikidata (matched by SEC CIK)Source
Semma Therapeutics
BiotechnologyCambridge, MA
Acquired by Vertex · Sep 2019
$129.3M raised (Form D) Last Form D Feb 2019
- Acquisition record· SEC EDGAR· Sep 3, 2019SEC 8-K filed by VERTEX PHARMACEUTICALS INC / MA: Semma Therapeutics became a wholly owned subsidiary of VertexSource
Urgent.ly
OtherVienna, VA
Acquired · Apr 2026
$128.7M raised (Form D) Last Form D Mar 2025
- Acquisition record· SEC EDGAR· Apr 28, 2026SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Alimera Sciences
PharmaceuticalsAlpharetta, GA
Acquired by ANI PHARMACEUTICALS INC · Sep 2024
$128.5M raised (Form D) Last Form D May 2023
- Acquisition record· SEC EDGAR· Sep 16, 2024SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website alimerasciences.com: listed by Wikidata (matched by SEC CIK)Source
- Acquisition record· SEC EDGAR· Sep 20, 2024SEC 8-K filed by ANI PHARMACEUTICALS INC: Alimera Sciences became a wholly owned subsidiary of ANI PHARMACEUTICALS INCSource
Heska
Other Health CareLoveland, CO
Acquired · Jun 2023
$128.5M raised (Form D) Last Form D Apr 2020
- Acquisition record· SEC EDGAR· Jun 13, 2023SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Internet Archive· Oct 18, 2026Website heska.com: archived copy of the site from around the company's last raise shows its name and HQ locationSource
Cision
OtherChicago, IL
Acquired · Jan 2020
$128.3M raised (Form D) Last Form D Feb 2019
- Acquisition record· SEC EDGAR· Jan 31, 2020SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website cision.com: listed by Wikidata (matched by SEC CIK)Source
theMaven
Other TechnologyNew York, NY
Acquired by Integrated · Nov 2016
$128.2M raised (Form D) Last Form D Jun 2021
- Acquisition record· SEC EDGAR· Nov 7, 2016SEC 8-K filed by INTEGRATED SURGICAL SYSTEMS INC: theMaven became a wholly owned subsidiary of IntegratedSource
Allakos
BiotechnologySan Carlos, CA
Acquired · May 2025
$128.1M raised (Form D) Last Form D Dec 2017
- Acquisition record· SEC EDGAR· May 15, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Acquisition record· SEC EDGAR· Apr 15, 2025SEC EX-99.A1A filed by Allakos Inc.: Allakos became a wholly owned subsidiarySource
IsoPlexis
Other TechnologyBranford, CT
Acquired by Berkeley Lights · Mar 2023
$127.0M raised (Form D) Last Form D Jan 2021
- Acquisition record· SEC EDGAR· Mar 22, 2023SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Acquisition record· SEC EDGAR· Mar 6, 2023SEC EX-99.1 filed by Berkeley Lights, Inc.: IsoPlexis became a wholly owned subsidiary of Berkeley LightsSource
- Company website· Internet Archive· Oct 18, 2026Website isoplexis.com: archived copy of the site from around the company's last raise shows its name and HQ locationSource
NGM Biopharmaceuticals
BiotechnologySouth San Francisco, CA
Acquired · Apr 2024
$126.7M raised (Form D) Last Form D Mar 2015
- Acquisition record· SEC EDGAR· Apr 5, 2024SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website ngmbio.com: listed by Wikidata (matched by SEC CIK)Source
Infleqtion
Other TechnologyLouisville, CO
Acquired by CCX · Mar 2026
$126.5M raised (Form D) Last Form D Feb 2026
- Acquisition record· SEC EDGAR· Mar 31, 2026SEC EX-99.2 filed by Infleqtion, Inc.: Infleqtion became a wholly owned subsidiary of CCXSource
- Company website· Company website· Oct 18, 2026Website infleqtion.com: site shows the company name and its HQ locationSource
TP Therapeutics
PharmaceuticalsSan Diego, CA
Acquired · Aug 2022
$126.4M raised (Form D) Last Form D Oct 2018
- Acquisition record· SEC EDGAR· Aug 17, 2022SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Internet Archive· Oct 18, 2026Website tptherapeutics.com: archived copy of the site from around the company's last raise shows its name and HQ locationSource
iTeos Therapeutics
Other TechnologyCambridge, MA
Acquired · Aug 2025
$125.4M raised (Form D) Last Form D Apr 2020
- Acquisition record· SEC EDGAR· Aug 29, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Sources: SEC Form D and EDGAR filings, Wikidata, the Internet Archive and companies' own websites. Amounts are totals sold as reported on Form D, in USD. If an entry about your company is wrong, use "Request a correction or removal" on it.